Notably, we identified aberrant activation of Nkp44+ NK cells as a hallmark of severe COPD, implicating innate lymphoid cell hyperactivity in chronic inflammation and tissue damage. This evidence concerns the gene NCR2 and chronic obstructive pulmonary disease.